Modelling of the pharmacodynamic interaction of an A1 adenosine receptor agonist and antagonist in vivo: N6-cyclopentyladenosine and 8-cyclopentyltheophylline.
about
Involvement of adenosine A1 and A2A receptors in the motor effects of caffeine after its acute and chronic administration.Sleep fragmentation attenuates the hypercapnic (but not hypoxic) ventilatory responses via adenosine A1 receptors in awake ratsRole of central and peripheral adenosine receptors in the cardiovascular responses to intraperitoneal injections of adenosine A1 and A2A subtype receptor agonists.Pharmacokinetic-haemodynamic relationships of 2-chloroadenosine at adenosine A1 and A2a receptors in vivo.Determination and validation of LJ-2698, a potent human A3 adenosine receptor antagonist, in rat plasma by liquid chromatography-tandem mass spectrometry and its application in pharmacokinetic study.Deoxyribose analogues of N6-cyclopentyladenosine (CPA): partial agonists at the adenosine A1 receptor in vivo.Direct cortical inputs erase long-term potentiation at Schaffer collateral synapses.Selectivity of action of 8-alkylamino analogues of N6-cyclopentyladenosine in vivo: haemodynamic versus anti-lipolytic responses in rats.Does permanent carotid artery occlusion produce a 'preconditioning-like' effect towards more severe hypotension in energy metabolites? Role of cerebral adenosine.Sleep fragmentation impairs ventilatory long-term facilitation via adenosine A1 receptors.
P2860
Q34191271-58D5E921-C22E-4889-B9DD-B3A5B2B78879Q34420132-DCE4ABC0-64A9-45B6-B3BF-2E7852F82A16Q35048671-7215A848-F602-4FDE-808F-25038723A910Q35873736-464C9400-1CD7-4FD2-B0C7-C0E57EC1BDC8Q38649750-12B5FEEE-2557-462E-99F7-C7F59B550953Q42081138-0060BB00-DA1C-4617-AB4F-80952186589AQ42441869-41052499-587C-4F1C-AC96-600AB1ACE980Q43183525-3ADC65B5-9644-45C2-BB44-F2E954F19CF6Q45282255-A18DC6FF-D418-4583-BFDC-247C7F1459DCQ46372834-A740F459-F605-494B-BD40-50C53BA9BF8A
P2860
Modelling of the pharmacodynamic interaction of an A1 adenosine receptor agonist and antagonist in vivo: N6-cyclopentyladenosine and 8-cyclopentyltheophylline.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh
1995年學術文章
@zh-hant
name
Modelling of the pharmacodynam ...... and 8-cyclopentyltheophylline.
@en
Modelling of the pharmacodynam ...... and 8-cyclopentyltheophylline.
@nl
type
label
Modelling of the pharmacodynam ...... and 8-cyclopentyltheophylline.
@en
Modelling of the pharmacodynam ...... and 8-cyclopentyltheophylline.
@nl
prefLabel
Modelling of the pharmacodynam ...... and 8-cyclopentyltheophylline.
@en
Modelling of the pharmacodynam ...... and 8-cyclopentyltheophylline.
@nl
P2093
P2860
P1476
Modelling of the pharmacodynam ...... and 8-cyclopentyltheophylline.
@en
P2093
P2860
P304
P356
10.1111/J.1476-5381.1995.TB15033.X
P407
P577
1995-08-01T00:00:00Z